A new research study shows that human behavior, like lockdowns, influences the evolution of COVID-19, leading to strains that are more transmissible earlier in their lifecycle.
Using artificial intelligence technology and mathematical modeling, a research group led by Nagoya University has revealed that human behavior, such as lockdowns and isolation measures, affect the evolution of new strains of COVID-19. SARS-CoV-2, the virus that causes COVID-19, developed to become more transmissible earlier in its lifecycle. The researcher's findings, published today (November 21) in the scientific journal Nature Communications, provide new insights into the relationship between how people behave and disease-causing agents.
Virus Evolution and Human Impact
As with any other living organism, viruses evolve over time. Those with survival advantages become dominant in the gene pool. Many environmental factors influence this evolution, including human behavior. By isolating sick people and using lockdowns to control outbreaks, humans may alter virus evolution in complicated ways. Predicting how these changes occur is vital to develop adaptive treatments and interventions.
Viral Load and Transmission
An important concept in this interaction is viral load, which refers to the amount or concentration of a virus present per ml of a bodily fluid. In SARS-CoV-2, a higher viral load in respiratory secretions increases the risk of transmission through droplets.
Viral load relates to the potential to transmit a virus to others. For example, a virus like Ebola has an exceptionally high viral load, whereas the common cold has a low one. However, viruses must perform a careful balancing act, as increasing the maximum viral load can be advantageous, but an excessive viral load may cause individuals to become too sick to transmit the virus to others.
AI-Assisted Research Findings
The research group led by Professor Shingo Iwami at the Nagoya University Graduate School of Science identified trends using mathematical modeling with an artificial intelligence component to investigate previously published clinical data.
They found that the SARS-CoV-2 variants that were most successful at spreading had an earlier and higher peak in viral load. However, as the virus evolved from the pre-Alpha to the Delta variants, it had a shorter duration of infection.
The researchers also found that the decreased incubation period and the increased proportion of asymptomatic infections recorded as the virus mutated also affected virus evolution.
Evolution From Wuhan to Delta Strain
The results showed a clear difference. As the virus evolved from the Wuhan strain to the Delta strain, they found a 5-fold increase in the maximum viral load and a 1.5-fold increase in the number of days before the viral load peaked.
Human Behavior and Virus Evolution
Iwami and his colleagues suggest that human behavioral changes in response to the virus, designed to limit transmission, were increasing the selection pressure on the virus. This caused SARS-CoV-2 to be transmitted mainly during the asymptomatic and presymptomatic periods, which occur earlier in its infectious cycle. As a result, the viral load peak advanced to this period to spread more effectively in the earlier pre-symptomatic stages.
Public Health Strategies and Virus Evolution
When evaluating public health strategies in response to COVID-19 and any future potentially pandemic-causing pathogens, it is necessary to consider the impact of changes in human behavior on virus evolution patterns. "We expect that immune pressure from vaccinations and/or previous infections drives the evolution of SARS-CoV-2," Iwami said. "However, our study found that human behavior can also contribute to the virus's evolution in a more complicated manner, suggesting the need to reevaluate virus evolution."
Their study suggests the possibility that new strains of coronavirus evolved because of a complex interaction between clinical symptoms and human behavior. The group hopes that their research will speed up the establishment of testing regimes for adaptive treatment, effective screening, and isolation strategies.
Reference: "Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution" by Junya Sunagawa, Hyeongki Park, Kwang Su Kim, Ryo Komorizono, Sooyoun Choi, Lucia Ramirez Torres, Joohyeon Woo, Yong Dam Jeong, William S. Hart, Robin N. Thompson, Kazuyuki Aihara, Shingo Iwami and Ryo Yamaguchi, 21 November 2023, Nature Communications.
DOI: 10.1038/s41467-023-43043-2
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
